Skip to main content
Journal ArticleOPEN ACCESS

Narrowing in on neurogenesis

  • Fulmer T
Science-Business eXchange (2009) 2(23) 930-930
DOI: 10.1038/scibx.2009.930
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A quartet of papers reveal new mechanisms by which two key signaling molecules—mTOR and GSK3beta—could be targeted to either decrease or increase neurogenesis. The findings point to potential strategies to treat four CNS disorders: schizophrenia, Alzheimer's disease, epilepsy and obsessive-compulsive disorder.

Cite

CITATION STYLE

APA

Fulmer, T. (2009). Narrowing in on neurogenesis. Science-Business EXchange, 2(23), 930–930. https://doi.org/10.1038/scibx.2009.930

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free